Cellceutix’s Kevetrin Shows No Significant Indications Of Toxicity

Cellceutix has completed acute toxicity studies in mice and rats with its Kevetrin. In these studies, Kevetrin showed no significant indications of toxicity.

In the acute toxicity mouse study, animals were sorted into four groups of 20 animals, each comprised of ten male and ten female mice. One group served as the controls and the other three groups were administered a single dose of 150mg/kg, 200mg/kg or 300mg/kg of Kevetrin.

Repotedly, the animals were observed for 15 days. Data was periodically collected measuring food consumption, body weight and various blood chemistry parameters. At the conclusion of the 15 day trial, post-mortem examinations were made of all the mice. In this study, there were no significant indications of toxicity in the mice that had been dosed with Kevetrin.

Krishna Menon, president and chief scientific officer of Cellceutix, said: These results are consistent with other animal studies we have conducted. Coupled with the results previously disclosed of tumor growth delay in animal models of multi-drug resistant lung cancers, we consider this a significant milestone for our shareholders.